糖肾合剂治疗糖尿病肾病的临床观察

目的；观察中药复方糖肾合剂对糖尿病肾病患者血糖，尿白蛋白定量，高凝状态有氧化损伤的影响。方法：９３例糖尿病患者随机分为两组，通过糖肾合剂及胰岛素联合治疗与单纯用胰岛素治疗的比较观察，评价糖肾合剂对糖尿病患者空腹血糖，餐后２ｈ血糖，２４ｈ尿白蛋白，内皮素，α－颗粒膜蛋白１４０，红细胞超氧化物歧化酶，过氧化脂质的影响。

Clinical Study on Tangshen Mixture in Treating Diabetic Nephropathy

OBJECTIVE: To investigate the effects of Tangshen Mixture (TSM) on the serum glucose, quantity of proteinuria per 24 h, hypercoagulative status and oxidative injury in patients with diabetic nephropathy (DN). METHODS: Ninety-three patients with DN were randomly divided into treated group and control group. 48 patients in the former were treated with insulin and TSM, while the latter was treated with insulin alone. Before and after treatment, the levels of fasting blood glucose (FBG), 2 h after meal blood glucose (PBG), 24 h urinary albumin (24 h-pro), endothelin (ET), alpha-granule membrane glycoprotein-140 (GMP-140), erythrocyte superoxide dismutase (ESOD), lipid peroxidase (LPO) were measured. RESULTS: After two months treatment, compared with the control group the levels of ET and GMP-140, LPO, and 24 h-pro lowered obviously (P < 0.01, P < 0.05), and the level of ESOD increased (P < 0.05) in the treated group, no obvious change was found in control grout after treatment. CONCLUSION: TSM could improve the hypercoagulative status, alleviate the renal free radical disturbances, and reduce the urinary protein loss.